{"id":"https://openalex.org/W4206569802","doi":"https://doi.org/10.3389/fimmu.2021.816646","title":"A Novel Humanized Anti-Interleukin-6 Antibody HZ0408b With Anti-Rheumatoid Arthritis Therapeutic Potential","display_name":"A Novel Humanized Anti-Interleukin-6 Antibody HZ0408b With Anti-Rheumatoid Arthritis Therapeutic Potential","publication_year":2022,"publication_date":"2022-01-19","ids":{"openalex":"https://openalex.org/W4206569802","doi":"https://doi.org/10.3389/fimmu.2021.816646","pmid":"https://pubmed.ncbi.nlm.nih.gov/35126375","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8808405"},"language":"en","primary_location":{"id":"doi:10.3389/fimmu.2021.816646","doi":"https://doi.org/10.3389/fimmu.2021.816646","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2021.816646","pdf_url":null,"source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.3389/fimmu.2021.816646","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100442750","display_name":"Xiaolei Liu","orcid":"https://orcid.org/0000-0003-3771-4165","observed_orcids":["https://orcid.org/0000-0003-3771-4165"]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xiaolei Liu","raw_affiliation_strings":["Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, United States","institution_ids":["https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100361216","display_name":"Li Li","orcid":"https://orcid.org/0000-0002-6666-3830","observed_orcids":["https://orcid.org/0000-0002-6666-3830"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Li Li","raw_affiliation_strings":["IPHASE Therapeutic Ltd., Philadelphia, PA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IPHASE Therapeutic Ltd., Philadelphia, PA, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100391017","display_name":"Qian Wang","orcid":"https://orcid.org/0000-0001-8988-126X","observed_orcids":["https://orcid.org/0000-0001-8988-126X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Qian Wang","raw_affiliation_strings":["IPHASE Therapeutic Ltd., Philadelphia, PA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IPHASE Therapeutic Ltd., Philadelphia, PA, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111527326","display_name":"Fengchao Jiang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fengchao Jiang","raw_affiliation_strings":["IPHASE Therapeutic Ltd., Philadelphia, PA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IPHASE Therapeutic Ltd., Philadelphia, PA, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100415684","display_name":"Pei Zhang","orcid":"https://orcid.org/0000-0002-3297-899X","observed_orcids":["https://orcid.org/0000-0002-3297-899X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pei Zhang","raw_affiliation_strings":["IPHASE Therapeutic Ltd., Philadelphia, PA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IPHASE Therapeutic Ltd., Philadelphia, PA, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088552997","display_name":"Fei Guo","orcid":"https://orcid.org/0000-0003-3500-1006","observed_orcids":["https://orcid.org/0000-0003-3500-1006"]},"institutions":[{"id":"https://openalex.org/I200296433","display_name":"Chinese Academy of Medical Sciences & Peking Union Medical College","ror":"https://ror.org/02drdmm93","country_code":"CN","type":"education","lineage":["https://openalex.org/I200296433"]},{"id":"https://openalex.org/I4405272564","display_name":"National Health Commission of the People's Republic of China","ror":"https://ror.org/04bdenw41","country_code":"CN","type":"government","lineage":["https://openalex.org/I4405272564"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Fei Guo","raw_affiliation_strings":["National Health Commission (NHC) Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, and Center for AIDS Research, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Health Commission (NHC) Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, and Center for AIDS Research, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China","institution_ids":["https://openalex.org/I200296433","https://openalex.org/I4405272564"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100346679","display_name":"Hongjun Liu","orcid":"https://orcid.org/0000-0003-0069-0745","observed_orcids":["https://orcid.org/0000-0003-0069-0745"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Hongjun Liu","raw_affiliation_strings":["IPHASE Therapeutic Ltd., Philadelphia, PA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IPHASE Therapeutic Ltd., Philadelphia, PA, United States","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5057147306","display_name":"Jian Yuan Huang","orcid":"https://orcid.org/0000-0002-1649-0038","observed_orcids":["https://orcid.org/0000-0002-1649-0038"]},"institutions":[{"id":"https://openalex.org/I2801875870","display_name":"Coriell Institute For Medical Research","ror":"https://ror.org/04npwsp41","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I2801875870"]},{"id":"https://openalex.org/I4210089330","display_name":"Cooper Medical School of Rowan University","ror":"https://ror.org/007evha27","country_code":"US","type":"education","lineage":["https://openalex.org/I4210089330","https://openalex.org/I4210157085","https://openalex.org/I44265643"]},{"id":"https://openalex.org/I84392919","display_name":"Temple University","ror":"https://ror.org/00kx1jb78","country_code":"US","type":"education","lineage":["https://openalex.org/I84392919"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jian Huang","raw_affiliation_strings":["Cooper Medical School of Rowan University, Camden, NJ, United States","Coriell Institute for Medical Research, Camden, NJ, United States","Temple University Lewis Katz School of Medicine, Center for Metabolic Disease Research, Philadelphia, PA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cooper Medical School of Rowan University, Camden, NJ, United States","institution_ids":["https://openalex.org/I4210089330"]},{"raw_affiliation_string":"Coriell Institute for Medical Research, Camden, NJ, United States","institution_ids":["https://openalex.org/I2801875870"]},{"raw_affiliation_string":"Temple University Lewis Katz School of Medicine, Center for Metabolic Disease Research, Philadelphia, PA, United States","institution_ids":["https://openalex.org/I84392919"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5057147306","https://openalex.org/A5088552997","https://openalex.org/A5100346679"],"corresponding_institution_ids":["https://openalex.org/I200296433","https://openalex.org/I2801875870","https://openalex.org/I4210089330","https://openalex.org/I4405272564","https://openalex.org/I84392919"],"apc_list":{"value":2950,"currency":"USD","value_usd":2950},"apc_paid":{"value":2950,"currency":"USD","value_usd":2950},"fwci":2.1994,"has_fulltext":true,"cited_by_count":15,"citation_normalized_percentile":{"value":0.87626123,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":92,"max":97},"biblio":{"volume":"12","issue":null,"first_page":"816646","last_page":"816646"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.9794999957084656,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.9794999957084656,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.016499999910593033,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/interleukin-6","display_name":"interleukin-6","score":0.9240000247955322},{"id":"https://openalex.org/keywords/anti-il-6-monoclonal-antibody","display_name":"anti-IL-6 monoclonal antibody","score":0.8980000019073486},{"id":"https://openalex.org/keywords/humanized-antibody","display_name":"humanized monoclonal antibody","score":0.8510000109672546},{"id":"https://openalex.org/keywords/rheumatoid-arthritis","display_name":"rheumatoid arthritis","score":0.9819999933242798},{"id":"https://openalex.org/keywords/siltuximab","display_name":"siltuximab","score":0.8059999942779541},{"id":"https://openalex.org/keywords/olokizumab","display_name":"olokizumab","score":0.9670000076293945},{"id":"https://openalex.org/keywords/collagen-induced-arthritis","display_name":"collagen-induced arthritis","score":0.7210000157356262},{"id":"https://openalex.org/keywords/cynomolgus-monkeys","display_name":"Macaca fascicularis","score":0.8640000224113464},{"id":"https://openalex.org/keywords/c-reactive-protein","display_name":"C-reactive protein","score":0.7910000085830688},{"id":"https://openalex.org/keywords/joint-swelling","display_name":"joint swelling","score":0.7929999828338623}],"concepts":[{"id":"https://openalex.org/C2777575956","wikidata":"https://www.wikidata.org/wiki/Q187255","display_name":"Rheumatoid arthritis","level":2,"score":0.7554962635040283},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.7408785820007324},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7209534645080566},{"id":"https://openalex.org/C2777092746","wikidata":"https://www.wikidata.org/wiki/Q5939625","display_name":"Humanized antibody","level":4,"score":0.613983154296875},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5920185446739197},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5799669027328491},{"id":"https://openalex.org/C2777077863","wikidata":"https://www.wikidata.org/wiki/Q170990","display_name":"Arthritis","level":2,"score":0.5764890909194946},{"id":"https://openalex.org/C2776156784","wikidata":"https://www.wikidata.org/wiki/Q3491954","display_name":"Humanized mouse","level":3,"score":0.5211158394813538},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.499114990234375},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.44753316044807434},{"id":"https://openalex.org/C11988809","wikidata":"https://www.wikidata.org/wiki/Q412889","display_name":"Interleukin 6","level":3,"score":0.4202905297279358},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.41921091079711914}],"mesh":[{"descriptor_ui":"D000093242","descriptor_name":"Interleukin-6 Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000685","descriptor_name":"Serum Amyloid A Protein","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001172","descriptor_name":"Arthritis, Rheumatoid","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D001172","descriptor_name":"Arthritis, Rheumatoid","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D001172","descriptor_name":"Arthritis, Rheumatoid","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004198","descriptor_name":"Disease Susceptibility","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008252","descriptor_name":"Macaca fascicularis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015551","descriptor_name":"Autoimmunity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018501","descriptor_name":"Antirheumatic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018501","descriptor_name":"Antirheumatic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D019468","descriptor_name":"Disease Management","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019947","descriptor_name":"Receptors, Interleukin-6","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":7,"locations":[{"id":"doi:10.3389/fimmu.2021.816646","doi":"https://doi.org/10.3389/fimmu.2021.816646","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2021.816646","pdf_url":null,"source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:8808405","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/8808405","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Immunol","raw_type":"Text"},{"id":"pmid:35126375","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35126375","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in immunology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:6ddddc7a77f54082ba3920ae274621f6","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/6ddddc7a77f54082ba3920ae274621f6","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Immunology, Vol 12 (2022)","raw_type":"article"},{"id":"pmh:oai:null:20.500.12613/7616","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/20.500.12613/7616","pdf_url":null,"source":{"id":"https://openalex.org/S4306402624","display_name":"TUScholarShare (Temple University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I84392919","host_organization_name":"Temple University","host_organization_lineage":["https://openalex.org/I84392919"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Journal article"},{"id":"pmh:oai:scholarshare.temple.edu:20.500.12613/8110","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/20.500.12613/8110","pdf_url":null,"source":{"id":"https://openalex.org/S4306402624","display_name":"TUScholarShare (Temple University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I84392919","host_organization_name":"Temple University","host_organization_lineage":["https://openalex.org/I84392919"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Journal article"},{"id":"pmh:oai:scholarshare.temple.edu:20.500.12613/9301","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/20.500.12613/9301","pdf_url":null,"source":{"id":"https://openalex.org/S4306402624","display_name":"TUScholarShare (Temple University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I84392919","host_organization_name":"Temple University","host_organization_lineage":["https://openalex.org/I84392919"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Journal article"}],"best_oa_location":{"id":"doi:10.3389/fimmu.2021.816646","doi":"https://doi.org/10.3389/fimmu.2021.816646","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2021.816646","pdf_url":null,"source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320312387","display_name":"Temple University","ror":"https://ror.org/00kx1jb78"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":33,"referenced_works":["https://openalex.org/W91258909","https://openalex.org/W301751650","https://openalex.org/W1586828706","https://openalex.org/W1967129318","https://openalex.org/W1974357188","https://openalex.org/W1983224547","https://openalex.org/W1988375787","https://openalex.org/W1995287920","https://openalex.org/W2002076761","https://openalex.org/W2013714853","https://openalex.org/W2022713850","https://openalex.org/W2029275361","https://openalex.org/W2063512424","https://openalex.org/W2064998333","https://openalex.org/W2075097399","https://openalex.org/W2088316376","https://openalex.org/W2108062638","https://openalex.org/W2114448779","https://openalex.org/W2148658155","https://openalex.org/W2153216198","https://openalex.org/W2153853625","https://openalex.org/W2169031812","https://openalex.org/W2313039815","https://openalex.org/W2557016092","https://openalex.org/W2564331065","https://openalex.org/W2793477763","https://openalex.org/W2802379102","https://openalex.org/W3017957088","https://openalex.org/W3046501287","https://openalex.org/W3081923621","https://openalex.org/W3093261446","https://openalex.org/W3120542280","https://openalex.org/W4234268725"],"related_works":["https://openalex.org/W2064998333","https://openalex.org/W169058504","https://openalex.org/W4376135313","https://openalex.org/W2022713850","https://openalex.org/W2025569039","https://openalex.org/W2409917151","https://openalex.org/W7097438351","https://openalex.org/W2000846863","https://openalex.org/W2331885071","https://openalex.org/W2405110365"],"abstract_inverted_index":{"Interleukin-6":[0],"(IL-6),":[1],"a":[2,13,72,92,102,122,177],"pleiotropic":[3],"cytokine":[4],"that":[5,89,127,136,143,156,190],"regulates":[6],"immune":[7],"responses":[8],"and":[9,81,96,168,198],"inflammatory":[10],"reactions,":[11],"plays":[12],"pivotal":[14],"role":[15],"in":[16,36,47,130,149,176],"the":[17,28,48,56,164],"development":[18],"of":[19,24,166],"rheumatoid":[20],"arthritis":[21,167,180],"(RA).":[22],"Blockade":[23],"IL-6":[25,41,58,61,108,126],"signaling":[26,62,109],"with":[27,78],"monoclonal":[29],"antibody":[30],"(mAb)":[31],"represents":[32],"an":[33,112],"important":[34],"advancement":[35],"RA":[37,64,202],"treatment.":[38,65],"Although":[39],"two":[40],"receptor":[42],"antibodies":[43],"are":[44],"already":[45,129],"available":[46],"clinic,":[49],"there":[50],"is":[51,118,128,138],"no":[52],"mAb":[53,76,124,193],"specifically":[54],"targeting":[55],"human":[57,85],"to":[59,84,120],"block":[60],"for":[63,201],"In":[66],"this":[67],"study,":[68],"we":[69,154],"have":[70],"developed":[71],"novel":[73],"humanized":[74,123,191],"anti-IL-6":[75,114,192],"HZ-0408b":[77,90,100,117,137,157,194],"potent":[79,104],"binding":[80],"neutralizing":[82],"activity":[83],"IL-6.":[86],"We":[87,134],"demonstrated":[88],"has":[91,195],"high":[93],"species":[94],"specificity":[95],"low":[97],"cross-reactivity.":[98],"Moreover,":[99],"showed":[101],"more":[103],"inhibitory":[105],"effect":[106],"on":[107],"than":[110],"Siltuximab,":[111],"FDA-approved":[113],"chimeric":[115],"mAb.":[116],"comparable":[119],"Olokizumab,":[121],"against":[125],"phase":[131],"III":[132],"studies.":[133],"observed":[135],"well":[139],"tolerated":[140],"at":[141],"doses":[142],"can":[144],"achieve":[145],"therapeutic":[146],"serum":[147],"levels":[148,175],"cynomolgus":[150],"monkey.":[151],"Most":[152],"importantly,":[153],"proved":[155],"treatment":[158],"significantly":[159],"ameliorated":[160],"joint":[161],"swelling":[162],"after":[163],"onset":[165],"dramatically":[169],"reduced":[170],"plasma":[171],"C-reactive":[172],"protein":[173],"(CRP)":[174],"monkey":[178],"collagen-induced":[179],"(CIA)":[181],"model.":[182],"Collectively,":[183],"our":[184],"findings":[185],"using":[186],"non-human":[187],"primates":[188],"indicate":[189],"excellent":[196],"safety":[197],"efficacy":[199],"profiles":[200],"therapy.":[203]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2022-01-25T00:00:00"}